Vanda Pharmaceuticals Inc. (VNDA) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $7.08 (-0.35%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 5, 2025 | Madison El-Saadi | B.Riley Financial | $11.00 | +55.5% |
| Jul 11, 2024 | Charles Duncan | Cantor Fitzgerald | $11.00 | +55.5% |
Top Analysts Covering VNDA
VNDA vs Sector & Market
| Metric | VNDA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.20 | 2.24 | 2.41 |
| Analyst Count | 5 | 8 | 18 |
| Target Upside | +100.3% | +1150.1% | +14.9% |
| P/E Ratio | -1.83 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $61M | $61M | $62M | 3 |
| 2026-09-30 | $66M | $67M | $68M | 1 |
| 2026-12-31 | $73M | $74M | $75M | 2 |
| 2027-03-31 | $73M | $74M | $75M | 1 |
| 2027-06-30 | $82M | $83M | $84M | 2 |
| 2027-09-30 | $85M | $86M | $87M | 2 |
| 2027-12-31 | $90M | $92M | $93M | 1 |
| 2028-12-31 | $421M | $449M | $485M | 3 |
| 2029-12-31 | $542M | $577M | $624M | 2 |
| 2030-12-31 | $597M | $636M | $687M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.57 | $-0.56 | $-0.55 | 3 |
| 2026-09-30 | $-0.53 | $-0.52 | $-0.51 | 1 |
| 2026-12-31 | $-0.47 | $-0.47 | $-0.46 | 1 |
| 2027-03-31 | $-0.35 | $-0.34 | $-0.34 | 1 |
| 2027-06-30 | $-0.22 | $-0.21 | $-0.21 | 1 |
| 2027-09-30 | $-0.16 | $-0.15 | $-0.15 | 1 |
| 2027-12-31 | $-0.10 | $-0.10 | $-0.09 | 1 |
| 2028-12-31 | $-0.80 | $0.05 | $0.63 | 3 |
| 2029-12-31 | $0.80 | $0.86 | $0.96 | 1 |
| 2030-12-31 | $1.03 | $1.12 | $1.24 | 1 |
Frequently Asked Questions
What is the analyst consensus for VNDA?
The consensus among 5 analysts covering Vanda Pharmaceuticals Inc. (VNDA) is Buy with an average price target of $14.17.
What is the highest price target for VNDA?
The highest price target for VNDA is $11.00, set by Madison El-Saadi at B.Riley Financial on 2025-11-05.
What is the lowest price target for VNDA?
The lowest price target for VNDA is $11.00, set by Charles Duncan at Cantor Fitzgerald on 2024-07-11.
How many analysts cover VNDA?
5 analysts have issued ratings for Vanda Pharmaceuticals Inc. in the past 12 months.
Is VNDA a buy or sell right now?
Based on 5 analyst ratings, VNDA has a consensus rating of Buy (2.20/5) with a +100.3% upside to the consensus target of $14.17.
What are the earnings estimates for VNDA?
Analysts estimate VNDA will report EPS of $-0.56 for the period ending 2026-06-30, with revenue estimated at $61M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.